Comparing the Soluble Form of Recombinant Human Insulin-like Growth Factor-1 (rhIGF-1) in Escherichia coli Using Thioredoxin as Fused and Co-expressed Protein
- 1 June 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 31 (6) , 469-478
Abstract
Introduction: Insulin-like growth factor-1 (IGF-1) is a single-chain polypeptide with various physiological functions. Escherichia coli is one of the most desirable hosts for recombinant protein production, especially for human proteins whose post-translation modifications are not essential for their bioactivity, such as hIGF-1. Objectives: In this study, bacterial thioredoxin (Trx) was studied as a fused and non-fused protein to convert the insoluble form of recombinant human IGF-1 (rhIGF-1) to its soluble form in E. coli. Methods: The rhIGF-1 was expressed in the E. coli Origami strain in the form of fused-Trx. It was co-expressed with Trx and then purified and quantified. In the next step, the biological activity of rhIGF-1 was evaluated by alkaline phosphatase (ALP) activity assay in human adipose- derived stem cells (hASCs) regarding the differentiation enhancement effect of IGF-1 through the osteogenic process. Results: Results showed that Trx in both the fused and non-fused forms had a positive effect on the production of the soluble form of rhIGF-1. A significant increase in ALP activity in hASCs after rhIGF-1 treatment was observed, confirming protein bioactivity. Conclusion: It was strongly suggested that the overproduction of Trx could increase the solubility of co-expressed recombinant proteins by changing the redox state in E. coli cells.Keywords
Funding Information
- School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran (24636, IR.SBMU.RETECH.REC.1400.099)
This publication has 40 references indexed in Scilit:
- Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to treat osteoporosisComposites Part B: Engineering, 2023
- Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosisComposites Part B: Engineering, 2023
- Strategies to enhance soluble production of heterologous proteins in Escherichia coliBiologia, 2022
- A protocol for recombinant protein quantification by densitometryMicrobiologyopen, 2020
- Fusion tags to enhance heterologous protein expressionApplied Microbiology and Biotechnology, 2020
- Soluble expression of IGF1 fused to DsbA in SHuffle™ T7 strain: optimization of expression and purification by Box-Behnken designApplied Microbiology and Biotechnology, 2019
- An efficient method for bacterial production and activity assessment of recombinant human insulin like growth factor 1Molecular Biology Reports, 2018
- Expression and efficient purification of tag-cleaved active recombinant human insulin-like growth factor-II from Escherichia coliBiotechnology and Bioprocess Engineering, 2015
- Enhancement of soluble protein expression through the use of fusion tagsCurrent Opinion in Biotechnology, 2006
- Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systemsApplied Microbiology and Biotechnology, 2006